Sector ratings Laboratorios Farmaceuticos Rovi, S.A.

Stocks

Real-time Estimate Tradegate 07:14:34 08/09/2026 pm IST			5-day change	1st Jan Change
58.55 ^EUR	-0.34%		-2.33%	-7.72%

23/07	Laboratorios Farmaceuticos Rovi, S.A., H1 2026 Earnings Call, Jul 23, 2026
23/07	Laboratorios Farmaceuticos Rovi, S.A. Reports Earnings Results for the Half Year Ended June 30, 2026	CI

Sector:

Location:

X axis:

Main competitors

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Capi.($)	Investor	ESG MSCI	Fundamentals	Global Valuation
LABORATORIOS FARMACEUTICOS ROVI, S.A.	349.38Cr		BBB
ELI LILLY AND COMPANY	1,02400Cr		A
JOHNSON & JOHNSON	66TCr	-	BBB	-	-
ABBVIE INC.	45TCr		AAA		-
ROCHE HOLDING AG	35TCr		AA
NOVARTIS AG	29TCr		AAA
ASTRAZENECA PLC	25TCr		A
AMGEN INC.	24TCr		A
NOVO NORDISK A/S	21TCr		BBB
GILEAD SCIENCES, INC.	19TCr		AA
PFIZER INC.	16TCr		A
VERTEX PHARMACEUTICALS INCORPORATED	14TCr		AA
BRISTOL-MYERS SQUIBB COMPANY	14TCr		A
SANOFI	11TCr		A
GSK PLC	9.97TCr		AA
CHUGAI PHARMACEUTICAL CO., LTD.	7TCr		AA
TAKEDA PHARMACEUTICAL COMPANY LIMITED	5.98TCr		AA
BAYER AG	5.56TCr		AA
JIANGSU HENGRUI PHARMACEUTICALS CO.,LTD	4.54TCr		AA
TEVA PHARMACEUTICAL INDUSTRIES LIMITED	4.24TCr		-
Average	22.93TCr		AA
Weighted average by Cap.			AA